Form 4: Eli Lilly Director Acquires Shares Under Deferral Plan

Director Ralph Alvarez acquired 15.561 shares of Eli Lilly & Co common stock under the company's Directors' Deferral Plan.

Summary

• Ralph Alvarez, a director of Eli Lilly & Co, acquired 15.561 shares of common stock on May 19, 2025.
• The acquisition was made under the Lilly Directors' Deferral Plan as a deferral of cash compensation.
• The price per share was $755.11.
• Following the transaction, Alvarez directly owns 54,862.696 shares of Eli Lilly & Co.
• The acquired shares will be settled in shares of common stock following Alvarez's separation from service.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. It reflects a director increasing their stake in the company, which is generally seen as a positive sign, but it's part of a pre-arranged compensation plan.

Positives

• The director's participation in the deferral plan demonstrates confidence in the company's future performance.

Future Outlook

The acquired shares will be settled in shares of common stock following the reporting person's separation from service.

Industry Context

This filing reflects routine transactions related to executive compensation and is typical for publicly traded companies. Directors often participate in stock deferral plans to align their interests with those of shareholders.

Stakeholder Impact

• The transaction signals confidence from a company director, which can positively influence shareholder sentiment.

Key Dates

Keywords

Director, Share Acquisition, Deferred Compensation, Lilly Directors' Deferral Plan, Common Stock, Ralph Alvarez, Eli Lilly & Co, LLY